Vera Therapeutics, Inc.
Total Trades
111
Buys
26
Sells
53
Largest Trade
N/A
Insiders
17
Institutional Funds
157
Inst. Value
$1M+
Activist Filings
44
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Brenner Robert | Chief Medical Offi… | SELL | $50K–$100K | 2K | $41.98 | Feb 26, 2026 |
| Young Joseph R | SVP | SELL | $100K–$500K | 3K | $41.98 | Feb 26, 2026 |
| Grant Sean | CHIEF FINANCIAL OF… | SELL | $100K–$500K | 5K | $41.98 | Feb 26, 2026 |
| Fordyce Marshall | PRESIDENT AND CEO | SELL | $500K+ | 17K | $41.98 | Feb 26, 2026 |
| JOHNSON DAVID LEE | COO | SELL | $100K–$500K | 3K | $41.98 | Feb 26, 2026 |
| Turner William D. | Chief Regulatory O… | SELL | $50K–$100K | 2K | $41.98 | Feb 26, 2026 |
| Skelton Laurence Matthew | Chief Commercial O… | SELL | $50K–$100K | 2K | $41.98 | Feb 26, 2026 |
| Turner William D. | Chief Regulatory O… | EXERCISE | $100K–$500K | 10K | $15.53 | Dec 17, 2025 |
| Turner William D. | Chief Regulatory O… | SELL | $500K+ | 10K | $50.08 | Dec 17, 2025 |
| ENRIGHT PATRICK G | Director | BUY | $100K–$500K | 6K | $42.50 | Dec 16, 2025 |
| Turner William D. | Chief Regulatory O… | SELL | $100K–$500K | 10K | $45.31 | Dec 10, 2025 |
| Turner William D. | Chief Regulatory O… | EXERCISE | $100K–$500K | 10K | $15.53 | Dec 10, 2025 |
| Turner William D. | Chief Regulatory O… | EXERCISE | $100K–$500K | 10K | $15.53 | Dec 4, 2025 |
| Turner William D. | Chief Regulatory O… | SELL | $100K–$500K | 10K | $40.00 | Dec 4, 2025 |
| Carter Jason S | Chief Legal Officer | SELL | $100K–$500K | 4K | $27.82 | Nov 25, 2025 |
| Young Joseph R | SVP | SELL | $100K–$500K | 15K | $29.06 | Nov 14, 2025 |
| Young Joseph R | SVP | EXERCISE | $15K–$50K | 10K | $3.94 | Nov 14, 2025 |
| ENRIGHT PATRICK G | Director | BUY | $1M+ | 250K | $21.11 | Jun 26, 2025 |
| Fordyce Marshall | PRESIDENT AND CEO | SELL | $500K+ | 20K | $27.78 | Feb 27, 2025 |
| Fordyce Marshall | PRESIDENT AND CEO | EXERCISE | $50K–$100K | 18K | $2.90 | Jan 10, 2025 |
| Fordyce Marshall | PRESIDENT AND CEO | SELL | $500K+ | 18K | $41.74 | Jan 10, 2025 |
| Fordyce Marshall | PRESIDENT AND CEO | EXERCISE | $50K–$100K | 19K | $2.90 | Nov 27, 2024 |
| Fordyce Marshall | PRESIDENT AND CEO | SELL | $500K+ | 19K | $47.98 | Nov 27, 2024 |
| Fordyce Marshall | PRESIDENT AND CEO | EXERCISE | $50K–$100K | 31K | $2.90 | Nov 15, 2024 |
| Fordyce Marshall | PRESIDENT AND CEO | SELL | $1M+ | 31K | $49.50 | Nov 15, 2024 |
| SEIDENBERG BETH C | Director | SELL | $500K+ | 15K | $48.03 | Oct 30, 2024 |
| Fordyce Marshall | PRESIDENT AND CEO | SELL | $500K+ | 19K | $40.39 | Oct 25, 2024 |
| Fordyce Marshall | PRESIDENT AND CEO | EXERCISE | $50K–$100K | 19K | $2.90 | Oct 25, 2024 |
| Fordyce Marshall | PRESIDENT AND CEO | EXERCISE | $15K–$50K | 16K | $2.90 | Oct 11, 2024 |
| Fordyce Marshall | PRESIDENT AND CEO | SELL | $500K+ | 16K | $38.24 | Oct 11, 2024 |
| Fordyce Marshall | PRESIDENT AND CEO | SELL | $1M+ | 23K | $46.05 | Sep 27, 2024 |
| Fordyce Marshall | PRESIDENT AND CEO | EXERCISE | $50K–$100K | 23K | $2.90 | Sep 27, 2024 |
| Fordyce Marshall | PRESIDENT AND CEO | SELL | $1M+ | 30K | $36.84 | Aug 30, 2024 |
| Fordyce Marshall | PRESIDENT AND CEO | EXERCISE | $15K–$50K | 16K | $2.90 | Aug 30, 2024 |
| Fordyce Marshall | PRESIDENT AND CEO | SELL | $500K+ | 14K | $39.76 | Aug 23, 2024 |
| Young Joseph R | SVP | SELL | $100K–$500K | 6K | $40.00 | Apr 12, 2024 |
| Grant Sean | CHIEF FINANCIAL OF… | SELL | $1M+ | 118K | $39.58 | Apr 6, 2024 |
| Grant Sean | CHIEF FINANCIAL OF… | EXERCISE | $1M+ | 100K | $14.87 | Apr 6, 2024 |
| Katabi Maha | Director | SELL | $1M+ | 834K | $40.86 | Mar 26, 2024 |
| Katabi Maha | Director | BUY | $1M+ | 161K | $31.00 | Feb 1, 2024 |
| COMMODORE CAPITAL LP | 10% Owner | SELL | $1M+ | 1.1M | $18.00 | Jan 13, 2024 |
| Lin Celia | Chief Medical Offi… | SELL | $15K–$50K | 1K | $16.65 | Aug 23, 2023 |
| Curley Joanne | Chief Development … | SELL | $15K–$50K | 1K | $16.66 | Aug 23, 2023 |
| Fordyce Marshall | President and CEO | SELL | $50K–$100K | 5K | $16.66 | Aug 23, 2023 |
| Grant Sean | CFO | BUY | $50K–$100K | 5K | $16.60 | Jun 23, 2023 |
| COMMODORE CAPITAL LP | 10% Owner | BUY | $1M+ | 448K | $15.17 | Jun 22, 2023 |
| SEIDENBERG BETH C | Director | BUY | $15K–$50K | 2K | $7.24 | Apr 3, 2023 |
| SEIDENBERG BETH C | Director | BUY | $100K–$500K | 24K | $7.24 | Mar 30, 2023 |
| SEIDENBERG BETH C | Director | BUY | $15K–$50K | 3K | $7.24 | Mar 28, 2023 |
| SEIDENBERG BETH C | Director | BUY | $500K+ | 89K | $7.13 | Mar 21, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 157 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 3.1M | $1M+ | SH |
| Deep Track Capital, LP | 2.8M | $1M+ | SH |
| Sofinnova Investments, Inc. | 2.8M | $1M+ | SH |
| STATE STREET CORP | 2.7M | $1M+ | SH |
| Point72 Asset Management, L.P. | 1.7M | $1M+ | SH |
| Pictet Asset Management Holding SA | 1.4M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 1.2M | $1M+ | SH |
| ALLIANCEBERNSTEIN L.P. | 1.2M | $1M+ | SH |
| First Light Asset Management, LLC | 870K | $1M+ | SH |
| BRAIDWELL LP | 785K | $1M+ | SH |
| AMERICAN CENTURY COMPANIES INC | 733K | $1M+ | SH |
| First Turn Management, LLC | 602K | $1M+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 519K | $1M+ | SH |
| BNP PARIBAS FINANCIAL MARKETS | 475K | $1M+ | SH |
| Candriam S.C.A. | 450K | $1M+ | SH |
| Rhenman & Partners Asset Management AB | 420K | $1M+ | SH |
| ORBIMED ADVISORS LLC | 354K | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 351K | $1M+ | SH |
| TD ASSET MANAGEMENT INC | 326K | $1M+ | SH |
| TimesSquare Capital Management, LLC | 252K | $1M+ | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
Sofinnova Venture Partners X, L.P. ("SVP X")
SC 13D/A · Mar 5, 2026
3.9%
2.8M shares
SC 13G/A · Feb 5, 2026
4.1%
2.9M shares
SC 13G · Jan 30, 2026
5.0%
3.6M shares
T. Rowe Price Associates, Inc.
SC 13G/A · Nov 14, 2025
5.7%
3.7M shares
SC 13G · Aug 14, 2025
5.4%
3.4M shares
SC 13G · Jun 11, 2025
5.3%
3.3M shares
SC 13G/A · Feb 14, 2025
8.9%
5.6M shares
SC 13G/A · Nov 14, 2024
4.5%
2.5M shares
SC 13G/A · Nov 14, 2024
7.3%
3.9M shares
T. ROWE PRICE ASSOCIATES, INC. 52-0556948
SC 13G · Nov 14, 2024
7.2%
3.9M shares
Kynam Capital Management, LP 85-3660072
SC 13G/A · Nov 14, 2024
2.5%
1.6M shares
SC 13G · Nov 14, 2024
7.9%
4.3M shares
SC 13G/A · Nov 12, 2024
5.1%
2.8M shares
Longitude Capital Partners IV, LLC
SC 13D/A · Nov 5, 2024
5.5%
3.4M shares
Sofinnova Venture Partners X, L.P. (“SVP X”)
SC 13D/A · Mar 26, 2024
5.3%
2.8M shares
Sofinnova Venture Partners X, L.P. (“SVP X”)
SC 13D/A · Feb 21, 2024
6.9%
3.6M shares
SC 13G/A · Feb 14, 2024
0.0%
6 shares
SC 13G/A · Feb 14, 2024
12.3%
5.5M shares
SC 13G/A · Feb 14, 2024
11.3%
5.0M shares
SC 13G/A · Feb 14, 2024
3.6%
1.9M shares
Kynam Capital Management, LP 85-3660072
SC 13G/A · Feb 14, 2024
8.2%
3.7M shares
SC 13G · Feb 12, 2024
2.2%
1.1M shares
SC 13G · Jan 29, 2024
6.2%
2.8M shares
SC 13G/A · Nov 13, 2023
7.5%
3.3M shares
SC 13D/A · Aug 2, 2023
4.2%
1.9M shares
SC 13D/A · Jul 5, 2023
5.5%
2.4M shares
SC 13D/A · Apr 13, 2023
6.7%
3.0M shares
Longitude Capital Partners IV, LLC
SC 13D/A · Feb 16, 2023
8.2%
3.4M shares
SC 13G · Feb 16, 2023
5.6%
2.3M shares
SC 13G/A · Feb 14, 2023
0.0%
0 shares
SC 13G/A · Feb 14, 2023
7.2%
6 shares
Sofinnova Venture Partners X, L.P. (“SVP X”)
SC 13D/A · Feb 14, 2023
8.3%
3.5M shares
SC 13G · Feb 10, 2023
5.1%
1.4M shares
SC 13G/A · Feb 9, 2023
15.0%
4.1M shares
Sofinnova Venture Partners X, L.P. (“SVP X”)
SC 13D/A · Feb 4, 2023
11.5%
3.2M shares
Kleiner Perkins Caufield & Byers XVI, LLC (“KPCB XVI”)
SC 13G/A · Feb 3, 2023
4.7%
1.3M shares
SC 13G/A · Jan 27, 2023
6.9%
1.9M shares
SC 13D/A · Aug 11, 2022
11.1%
3.0M shares
SC 13D/A · Apr 7, 2022
11.1%
3.0M shares
Longitude Capital Partners IV, LLC
SC 13D/A · Apr 5, 2022
12.7%
3.4M shares
SC 13G · Feb 24, 2022
7.5%
2.0M shares
SC 13G/A · Feb 14, 2022
9.6%
6 shares
Kleiner Perkins Caufield & Byers XVI, LLC (“KPCB XVI”)
SC 13G · Feb 11, 2022
6.2%
1.3M shares
SC 13G · Jan 24, 2022
9.0%
1.9M shares